Evidence map›Paper›PMID 38158307›Full record

ReviewTrends in biotechnology2024

New dimensions of electrospun nanofiber material designs for biotechnological uses.

Meenakshi Kamaraj, Nafiseh Moghimi, Junjie Chen, Ramon Morales, Shixuan Chen, Ali Khademhosseini, Johnson V John

Abstract readReview
In one paragraph

Review in Trends in biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meenakshi KamarajTerasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
Nafiseh MoghimiTerasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
Junjie ChenTerasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
Ramon MoralesTerasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
Shixuan ChenZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of the Chinese Academy of Sciences, Wenzhou, Zhejiang 325000, China.
Ali KhademhosseiniTerasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA. Electronic address: khademh@terasaki.org.
Johnson V JohnTerasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA. Electronic address: jjohn@terasaki.org.

Funding

A Novel Semi-autonomous Surgeon-in-the-loop in situ Robotic Bioprinting System for Functional and Cosmetic Restoration of Volumetric Muscle Loss InjuriesDP2AR082471 · NIAMS · UNIVERSITY OF TEXAS AT AUSTIN · PI ALAMBEIGI, FARSHID · 2022 to 2025
$2.3M
Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repairR01DK134903 · NIDDK · TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION · PI Johnson Vitharikunnil John · 2023 to 2026
$2.2M
NIAMS NIH HHS DP2 AR082471NIDDK NIH HHS R01 DK134903
6 · The paper itself

Abstract

Electrospinning technology has garnered wide attention over the past few decades in various biomedical applications including drug delivery, cell therapy, and tissue engineering. This technology can create nanofibers with tunable fiber diameters and functionalities. However, the 2D membrane nature of the nanofibers, as well as the rigidity and low porosity of electrospun fibers, lower their efficacy in tissue repair and regeneration. Recently, new avenues have been explored to resolve the challenges associated with 2D electrospun nanofiber membranes. This review discusses recent trends in creating different electrospun nanofiber microstructures from 2D nanofiber membranes by using various post-processing methods, as well as their biotechnological applications.

Indexed as

BiotechnologyNanofibersTissue EngineeringBiocompatible MaterialsDrug Delivery SystemsHumansTissue ScaffoldsBiocompatible Materials3D expansionaerogelselectrospinninginjectablenanofibersporosity

Identifiers

PMID38158307
PMCPMC11065627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.